甲基巴多索隆
| CAS号 | 218600-53-4 | 货号 | BCP04660 |
| 中文名 | 甲基巴多索隆 | ||
| 英文名 | Bardoxolone methyl | ||
| 中文别名 | |||
| 英文别名 | CDDO Methyl ester; CDDOMe; NSC 713200; RTA 402; RTA-402; RTA402; TP-155; TP155; TP 155; | ||
| 分子式 | C32H43NO4 | 分子量 | 505.69 |
| 生物活性 | Bardoxolone methyl (also known as “RTA 402” and “CDDO-methyl ester”) is an orally-available first-in-class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. It is the most potent known inducer of the Nrf2 pathway to enter clinical development and works to suppress both oxidative stress and inflammation. Bardoxolone methyl is currently being developed by Reata Pharmaceuticals, Inc. in partnership with Abbott Laboratories and Kyowa Hakko Kirin, for the treatment of advanced chronic kidney disease (CKD) in type 2 diabetes mellitus patients. | ||
| 信号通路 | NFκB | ||
| 靶 点 | Keap1 Nrf2 | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！